0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Don’t have an account? Signup
Powered by :
Ibrutinib is a kinase inhibitor indicated for the treatment of adult patients with Chronic lymphocytic leukaemia (CLL)/Small lymphocytic lymphoma (SLL) with 17p deletion, and Waldenstrom's macroglobulinemia (WM).
Share this article
If you liked this article share it with your friends.they will thank you later
/smstreet/media/media_files/8TEGBfMfUwtp2njKzCKi.jpg)
1 Min read
/smstreet/media/agency_attachments/3LWGA69AjH55EG7xRGSA.png)
